Gainesville, FL26 Active Studies

Pulmonary Embolism Clinical Trials in Gainesville, FL

Find 26 actively recruiting pulmonary embolism clinical trials in Gainesville, FL. Connect with local research sites and explore new treatment options.

26
Active Trials
22
Sponsors
87,834
Enrolling

Recruiting Pulmonary Embolism Studies in Gainesville

About Pulmonary Embolism Clinical Trials in Gainesville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 26 pulmonary embolism clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 87,834 participants. Research is being sponsored by University of South Florida, Population Health Research Institute, Penumbra Inc. and 19 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Gainesville — FAQ

Are there pulmonary embolism clinical trials in Gainesville?

Yes, there are 26 pulmonary embolism clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gainesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.

Are clinical trials in Gainesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 26 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 17, 2026 from ClinicalTrials.gov